Neratinib Completed Phase 1 / 2 Trials for Advanced Malignant Solid Tumors / Neoplasms, Breast / Advanced Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01128842A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
NCT00768469Study Evaluating Safety And Tolerability, Solid Tumor
NCT00958724Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
NCT00146172Study Evaluating HKI-272 in Tumors